ImmunityBio, Inc. Annual Depreciation in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
ImmunityBio, Inc. quarterly/annual Depreciation history and growth rate from 2014 to 2023.
  • ImmunityBio, Inc. Depreciation for the quarter ending September 30, 2024 was $3.9M, a 4.88% decline year-over-year.
  • ImmunityBio, Inc. Depreciation for the twelve months ending September 30, 2024 was $15.8M, a 7.06% decline year-over-year.
  • ImmunityBio, Inc. annual Depreciation for 2023 was $16.5M, a 1.23% increase from 2022.
  • ImmunityBio, Inc. annual Depreciation for 2022 was $16.3M, a 14.8% increase from 2021.
  • ImmunityBio, Inc. annual Depreciation for 2021 was $14.2M, a 11.8% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $16.5M +$200K +1.23% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 $16.3M +$2.1M +14.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 $14.2M +$1.5M +11.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-19
2020 $12.7M +$4.3M +51.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $8.4M +$1.1M +15.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
2018 $7.3M +$4M +121% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-04
2017 $3.3M +$2.3M +230% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-25
2016 $1M +$900K +900% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-13
2015 $100K +$64K +178% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 $36K Jan 1, 2014 Dec 31, 2014 10-K 2017-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.